Fractyl Health today announced top-line six-month results from the Pivotal Cohort of its ongoing REMAIN-1 study (Pivotal ...

Singapore based clinical-stage biotech Adlai Nortye Group has entered into clinical trial collaboration and supply agreements ...

US biotech company Iambic Therapeutics (Nasdaq: IAM) has priced a $150 million initial public offering (IPO), securing ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended four novel medicines and two biosimilars ...

Cambridge, UK based Microbiotica, a clinical-stage biopharma company developing a pipeline of orally-dosed, precision ...

Belgian biotech Lakefront Biotherapeutics (Euronext: LKFT), formerly Galapagos, has sold its preclinical cell therapy ...

US genetic medicines developer Estuary Biotherapeutics today announced its launch with $103 million in total committed ...

Shares in Swedish biotech Modus Therapeutics fell by half in Stockholm trading on Thursday after the company paused ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is introducing a series of new measures to strengthen how ...

The US regulator, the Food and Drug Administration (FDA), has launched an initiative to reshape rare disease drug development ...

German drug discovery and development services company Evotec has appointed Joanna Holbrook as chief scientific officer (CSO) ...

Japan’s largest drugmaker Takeda today announced that Orzeyful (oveporexton) is now available in Japan and China for the ...